Dr. Nagourney's Blog

Email-box.png

Informative articles sent right to your inbox. Subscribe to Dr. Nagourney's blog today.

With an EVA-PCD Assay, It Can Be That Simple - End Stage CLL Success
By Robert A. Nagourney, MD
Shortly after I left the university and joined a medical oncology group, one of the junior members of the practice asked if I would cover for him during his summer vacation. Among the patients he signed over to me was a gentleman in his 60s...
Phar Lap and the Treatment of Leukemia
By Robert A. Nagourney, MD
Phar Lap (1926-1932) was a thoroughbred horse bred in New Zealand. After winning the Melbourne Cup and 37 other races, his...
Why I Do Chemosensitivity Testing
By Robert A. Nagourney, MD
My earliest experience in cancer research came during my first years of medical school. Working in a pharmacology laboratory, I...
The Avastin Saga Continues
By Robert A. Nagourney, MD
We previously wrote about bevacizumab (Avastin) and its approval for breast cancer. The early clinical trials revealed evidence...
Chronic Lymphocytic Leukemia (CLL) - Model for Functional Profiling
By Robert A. Nagourney, MD
Among the most common forms of leukemia in adults is chronic lymphocytic leukemia CLL.

most popular articles

patient story

How We Helped David Hanbidge

"I'll never forget the day when the doctor took my wife and me to a small back office and told us the horrible news…I had the very worst kind of lung cancer..."   Read about how we helped David.